Curocell (KRX: 372320)
Who is buying Curocell?
Between Sep 10, 2026 and Oct 13, 2026 (20 trading sessions), foreign investors net sold ₩1.8bn ($1M) of Curocell, the 195th largest foreign net sale among 1828 KOSDAQ stocks. Institutions net sold ₩0.4bn ($0M) and retail investors net bought ₩2.2bn ($2M) over the same window. Foreigners were net buyers on 8 of the 20 sessions.
Foreign investors hold 1.14% of Curocell's listed shares (KRX ownership data as of Oct 13, 2026), down from 1.62% twenty sessions earlier and 1.09% a year ago.
The stock closed at ₩23,150 on Oct 13, 2026: -3.54% over 20 sessions, -48.50% year-to-date, -41.98% over one year. The 52-week range is ₩20,650 – ₩66,000.
View chart data as a table
| Date | Close | Foreign net | Institutions | Retail |
|---|---|---|---|---|
| 2026-10-13 | ₩23,150 | +₩0.1bn | ₩-0.0bn | ₩-0.1bn |
| 2026-10-12 | ₩24,000 | ₩-0.3bn | +₩0.0bn | +₩0.3bn |
| 2026-10-08 | ₩26,150 | ₩-0.9bn | +₩0.0bn | +₩0.9bn |
| 2026-10-07 | ₩26,500 | +₩0.2bn | ₩-0.0bn | ₩-0.2bn |
| 2026-10-06 | ₩22,700 | ₩-0.2bn | +₩0.0bn | +₩0.2bn |
| 2026-10-02 | ₩23,000 | ₩-0.3bn | ₩-0.0bn | +₩0.3bn |
| 2026-10-01 | ₩22,850 | +₩0.2bn | +₩0.0bn | ₩-0.2bn |
| 2026-09-30 | ₩21,650 | +₩0.0bn | +₩0.0bn | ₩-0.0bn |
| 2026-09-29 | ₩21,650 | ₩-0.1bn | ₩-0.0bn | +₩0.1bn |
| 2026-09-28 | ₩21,600 | ₩-0.3bn | +₩0.0bn | +₩0.3bn |
| 2026-09-23 | ₩21,200 | +₩0.1bn | +₩0.0bn | ₩-0.1bn |
| 2026-09-22 | ₩20,900 | ₩-0.1bn | ₩-0.0bn | +₩0.1bn |
| 2026-09-21 | ₩21,050 | ₩-0.1bn | ₩-0.0bn | +₩0.1bn |
| 2026-09-18 | ₩21,450 | ₩-0.0bn | ₩-0.0bn | +₩0.1bn |
| 2026-09-17 | ₩21,500 | +₩0.0bn | +₩0.0bn | ₩-0.0bn |
| 2026-09-16 | ₩21,450 | ₩-0.2bn | ₩-0.0bn | +₩0.2bn |
| 2026-09-15 | ₩22,050 | +₩0.1bn | +₩0.0bn | ₩-0.1bn |
| 2026-09-14 | ₩22,000 | ₩-0.1bn | ₩-0.0bn | +₩0.1bn |
| 2026-09-11 | ₩22,850 | +₩0.0bn | +₩0.0bn | ₩-0.1bn |
| 2026-09-10 | ₩22,800 | ₩-0.0bn | ₩-0.4bn | +₩0.4bn |
| 2026-09-09 | ₩24,000 | ₩-0.1bn | ₩0.0bn | +₩0.1bn |
| 2026-09-08 | ₩23,700 | ₩-0.0bn | ₩-0.0bn | +₩0.1bn |
| 2026-09-07 | ₩24,000 | ₩-0.1bn | ₩-0.0bn | +₩0.1bn |
| 2026-09-04 | ₩24,050 | ₩-0.9bn | ₩-0.0bn | +₩0.9bn |
| 2026-09-03 | ₩24,050 | ₩-0.1bn | +₩0.0bn | +₩0.1bn |
| 2026-09-02 | ₩24,100 | ₩-0.0bn | ₩-0.0bn | +₩0.0bn |
| 2026-09-01 | ₩23,950 | ₩-0.1bn | ₩-0.0bn | +₩0.1bn |
| 2026-08-31 | ₩24,400 | ₩-0.1bn | ₩-0.0bn | +₩0.1bn |
| 2026-08-28 | ₩24,650 | +₩0.1bn | ₩-0.0bn | +₩0.0bn |
| 2026-08-27 | ₩25,000 | ₩-0.1bn | +₩0.0bn | +₩0.1bn |
| 2026-08-26 | ₩25,150 | +₩0.2bn | ₩0.0bn | ₩-0.2bn |
| 2026-08-25 | ₩24,100 | ₩-0.1bn | ₩-0.0bn | +₩0.1bn |
| 2026-08-24 | ₩23,800 | +₩0.3bn | +₩0.0bn | ₩-0.3bn |
| 2026-08-21 | ₩23,400 | ₩-0.2bn | ₩-0.0bn | +₩0.2bn |
| 2026-08-20 | ₩25,100 | ₩-0.1bn | ₩-0.0bn | ₩-0.0bn |
| 2026-08-19 | ₩24,700 | +₩0.2bn | ₩-0.0bn | ₩-0.2bn |
| 2026-08-18 | ₩24,600 | ₩-0.4bn | ₩-0.0bn | +₩0.4bn |
| 2026-08-14 | ₩26,150 | ₩-0.0bn | +₩0.0bn | +₩0.0bn |
| 2026-08-13 | ₩26,100 | ₩-0.1bn | ₩-0.0bn | +₩0.1bn |
| 2026-08-12 | ₩26,150 | +₩0.3bn | ₩-0.1bn | +₩0.4bn |
| 2026-08-11 | ₩27,150 | +₩0.0bn | ₩-0.1bn | +₩0.0bn |
| 2026-08-10 | ₩27,750 | +₩0.3bn | ₩-0.0bn | ₩-0.3bn |
| 2026-08-07 | ₩26,950 | +₩0.1bn | ₩-0.0bn | ₩-0.1bn |
| 2026-08-06 | ₩27,300 | +₩0.1bn | +₩0.0bn | ₩-0.1bn |
| 2026-08-05 | ₩27,150 | +₩0.0bn | ₩0.0bn | ₩-0.0bn |
| 2026-08-04 | ₩27,200 | +₩0.2bn | +₩0.0bn | ₩-0.2bn |
| 2026-08-03 | ₩24,950 | ₩-0.1bn | +₩0.1bn | +₩0.1bn |
| 2026-07-31 | ₩23,100 | +₩0.4bn | ₩-0.0bn | ₩-0.4bn |
| 2026-07-30 | ₩20,850 | +₩0.3bn | +₩0.0bn | ₩-0.3bn |
| 2026-07-29 | ₩21,150 | +₩0.3bn | ₩0.0bn | ₩-0.3bn |
| 2026-07-28 | ₩22,700 | +₩0.0bn | +₩0.0bn | ₩-0.1bn |
| 2026-07-27 | ₩24,350 | +₩0.1bn | +₩0.0bn | ₩-0.1bn |
| 2026-07-24 | ₩23,550 | ₩-0.1bn | ₩0.0bn | +₩0.1bn |
| 2026-07-23 | ₩23,950 | +₩0.2bn | ₩-0.0bn | ₩-0.2bn |
| 2026-07-22 | ₩22,400 | +₩0.3bn | +₩0.0bn | ₩-0.3bn |
| 2026-07-21 | ₩22,100 | ₩-0.1bn | ₩0.0bn | +₩0.1bn |
| 2026-07-20 | ₩22,450 | ₩-0.2bn | ₩0.0bn | +₩0.2bn |
| 2026-07-16 | ₩23,600 | +₩0.2bn | +₩0.1bn | ₩-0.2bn |
| 2026-07-15 | ₩24,150 | +₩0.2bn | +₩0.0bn | ₩-0.2bn |
| 2026-07-14 | ₩22,700 | +₩0.4bn | ₩-0.0bn | ₩-0.3bn |
| 2026-07-13 | ₩23,850 | +₩0.2bn | +₩0.0bn | ₩-0.1bn |
Investor flows summary
| Window | Foreign | (USD) | Institutions | Retail |
|---|---|---|---|---|
| 1 day | +₩0.1bn | +$0M | ₩-0.0bn | ₩-0.1bn |
| 5 days | ₩-1.1bn | $-1M | +₩0.0bn | +₩1.0bn |
| 20 days | ₩-1.8bn | $-1M | ₩-0.4bn | +₩2.2bn |
Positive = net buying, negative = net selling. Values aggregate the KRX main board and the NXT alternative venue.
Frequently asked questions
Are foreign investors buying Curocell stock?
Over the last 5 sessions foreign investors net sold ₩1.1bn ($1M) of Curocell; over 60 sessions they net sold ₩0.5bn ($0M); since Jan 1, 2026 they net sold ₩6.5bn ($5M). Over 20 sessions the stock is the 195th largest foreign net sale among 1828 KOSDAQ stocks.
How much of Curocell do foreign investors own?
Foreign investors own 1.14% of Curocell's shares as of Oct 13, 2026, versus 1.09% one year earlier. The figure is KRX's daily foreign holdings divided by listed shares, and it reflects trades settled through the previous session.
Who is on the other side — institutions or retail investors?
Over 20 sessions institutions net sold ₩0.4bn ($0M) and retail investors net bought ₩2.2bn ($2M) of Curocell. Retail investors have been absorbing what foreigners and institutions are selling.
Is Curocell listed on KOSPI or KOSDAQ?
Curocell (큐로셀) trades on KOSDAQ under KRX code 372320 in the Biotech & Pharma group, with a market capitalization of ₩0T ($0.3B). Daily net flows by investor type are published by KRX after each session and combine the KRX main board with the NXT venue.
Annual financials
| Fiscal year | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| 2023 | ₩0bn ($0M) | – | -₩31bn (-$23M) | -₩30bn (-$22M) |
| 2024 | ₩0bn ($0M) | – | -₩37bn (-$27M) | -₩38bn (-$29M) |
| 2025 | ₩0bn ($0M) | – | -₩36bn (-$27M) | -₩46bn (-$35M) |
Consolidated (K-IFRS) where available, from DART regulatory filings. USD figures converted at the current rate (₩1333.09/$) for reference only.